Peer-reviewed articles

Alsinnawi M, Quinlan MR, Deady S, Kiely EA. Regional variations in testicular cancer rates in Ireland. Ir J Med Sci. 2011;180(1):109-114. doi:10.1007/s11845-010-0643-7

Ó Céilleachair A, Finn C, Deady S, Carsin AE, Sharp L. Have developments in palliative care services impacted on place of death of colorectal cancer patients in Ireland? A population-based study. Ir J Med Sci. 2011;180(1):91-96. doi:10.1007/s11845-010-0607-y

Carsin AE, Sharp L, Comber H. Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland. Br J Dermatol. 2011;164(4):822-829. doi:10.1111/j.1365-2133.2011.10238.x

Marcos-Gragera R, Allemani C, Tereanu C, et al. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project. Haematologica. 2011;96(5):720-728. doi:10.3324/haematol.2010.034264

Comber H, Deady S, Montgomery E, Gavin A. Drinking water fluoridation and osteosarcoma incidence on the island of Ireland. Cancer Causes Control. 2011;22(6):919-924. doi:10.1007/s10552-011-9765-0

Ali RAR, Dooley C, Comber H, Newell J, Egan LJ. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9(7):584-589.e1-2. doi:10.1016/j.cgh.2011.04.016

Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol. 2011;29(19):2635-2644. doi:10.1200/JCO.2010.33.5422

Boyle E, Timmons A, Al-Akash M, et al. The management of rectal cancer in Ireland in 2007--room for improvement? Surgeon. 2011;9(4):179-186. doi:10.1016/j.surge.2010.09.006

Walsh PM, Byrne J, Capra M, Comber H. Childhood cancer survival in Ireland: temporal, regional and deprivation-related patterns. Eur J Cancer. 2011;47(12):1852-1862. doi:10.1016/j.ejca.2011.03.021

Mulholland HG, Murray LJ, Anderson LA, Cantwell MM, FINBAR study group. Vitamin D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions. Br J Nutr. 2011;106(5):732-741. doi:10.1017/S0007114511000742

Gatta G, Van Der Zwan JM, Casali PG, et al. Rare cancers are not so rare: The rare cancer burden in Europe. European Journal of Cancer. 2011;47(17):2493-2511. doi:10.1016/j.ejca.2011.08.008

Ho WL, Comber H, Hill ADK, Murphy GM. Malignant melanoma and breast carcinoma: a bidirectional correlation. Ir J Med Sci. 2011;180(4):901-903. doi:10.1007/s11845-009-0297-5

Sharp L, Timmons A. Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland. J Cancer Surviv. 2011;5(4):382-394. doi:10.1007/s11764-011-0183-9

Kelly M, Sharp L, Dwane F, Kelleher T, Comber H. Factors predicting hospital length-of-stay and readmission after colorectal resection: a population-based study of elective and emergency admissions. BMC Health Serv Res. 2012;12:77. doi:10.1186/1472-6963-12-77

Ó Céilleachair A, Costello L, Finn C, et al. Inter-relationships between the economic and emotional consequences of colorectal cancer for patients and their families: a qualitative study. BMC Gastroenterol. 2012;12:62. doi:10.1186/1471-230X-12-62

Sharp L, Tilson L, Whyte S, et al. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. Br J Cancer. 2012;106(5):805-816. doi:10.1038/bjc.2011.580

Kiderlen M, Bastiaannet E, Walsh PM, et al. Surgical treatment of early stage breast cancer in elderly: an international comparison. Breast Cancer Res Treat. 2012;132(2):675-682. doi:10.1007/s10549-011-1892-5

Oberaigner W, Minicozzi P, Bielska-Lasota M, et al. Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade. Acta Oncologica. 2012;51(4):441-453. doi:10.3109/0284186X.2011.653437

Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: a perspective review. Ther Adv Med Oncol. 2012;4(3):113-125. doi:10.1177/1758834012439738

Hanly P, Timmons A, Walsh PM, Sharp L. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach. Value Health. 2012;15(3):429-436. doi:10.1016/j.jval.2011.12.012

Glover JA, Bannon FJ, Hughes CM, et al. Increased diagnosis and detection rates of carcinoma in situ of the breast. Breast Cancer Res Treat. 2012;133(2):779-784. doi:10.1007/s10549-012-1975-y

Lubin JH, Cook MB, Pandeya N, et al. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett’s Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol. 2012;36(3):306-316. doi:10.1016/j.canep.2012.03.001

Sharp L, Cotton S, Thornton A, et al. Which women default from follow-up cervical cytology tests? A cohort study within the TOMBOLA trial. Cytopathology. 2012;23(3):150-160. doi:10.1111/j.1365-2303.2011.00848.x

Crocetti E, Trama A, Stiller C, et al. Epidemiology of glial and non-glial brain tumours in Europe. European Journal of Cancer. 2012;48(10):1532-1542. doi:10.1016/j.ejca.2011.12.013

Sant M, Minicozzi P, Lagorio S, et al. Survival of European patients with central nervous system tumors. Intl Journal of Cancer. 2012;131(1):173-185. doi:10.1002/ijc.26335